Effects of Esketamine Combined With Remimazolam Tosylate on Hemodynamics During Cardiovascular Anesthesia
Clinical and Translational Science · 2025-08 · 18 (8)
DOI: 10.1111/cts.70232 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Translational Science, online erschienen am 28.07.2025. Verfasst von Lei Xi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Hemodynamics, Ketamine, Heart Valve Prosthesis Implantation, Benzodiazepines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study aimed to evaluate the effects of esketamine combined with remimazolam tosylate on hemodynamic stability, cerebral oxygen metabolism, and cognitive outcomes in patients undergoing heart valve replacement. Seventy‐eight patients were randomized to Group C (dexmedetomidine hydrochloride) or Group R (esketamine + remimazolam tosylate). The following parameters were measured: multiple time points, including mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), arterial‐jugular vein oxygen content difference (Da‐jvO 2 ), cerebral oxygen uptake rate (CERO 2 ), and biomarkers of myocardial injury (cTnI, CK‐MB, FABP) at baseline (T0), incision (T1), sternotomy (T2), pre‐cardiopulmonary bypass (T3), and post‐surgery (T4). Cognitive function was assessed using the Mini‐Mental State Examination (MMSE) and Confusion Assessment Method (CAM). Group R showed prolonged values of lower RR in T1 to T4 than Group C ( p < 0.05). The Da‐jvO 2 and CERO 2 were found to be much higher in Group R in T2, T3, and T4 ( p < 0.05). This is an indication of improved cerebral oxygen metabolism. MMSE scores were elevated in Group R: the incidence of delirium and CAM Scores were lower compared with Group C ( p < 0.05). This indicates better cognitive outcomes. Also, cTnI, CK‐MB, and FABP, myocardial injury markers, were significantly reduced in Group R at postoperative 24 and 72 h ( p < 0.05), indicating reduced myocardial injury. The combination of esketamine and remimazolam tosylate offers hemodynamic stability, enhances cerebral oxygen metabolism, improves cognitive function, and reduces myocardial injury in patients undergoing heart valve replacement surgery. This approach might provide significant benefits in cardiovascular anesthesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
- Department of Radiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Zitieren
APA
Xi, L., Liu, H., Tang, X., & Jiang, Z. (2025). Effects of Esketamine Combined With Remimazolam Tosylate on Hemodynamics During Cardiovascular Anesthesia. Clinical and Translational Science, 18(8). https://doi.org/10.1111/cts.70232
Vancouver
Xi L, Liu H, Tang X, Jiang Z. Effects of Esketamine Combined With Remimazolam Tosylate on Hemodynamics During Cardiovascular Anesthesia. Clinical and Translational Science. 2025;18(8). doi:10.1111/cts.70232
BibTeX
@article{Xi2025,
author = {Xi, Lei and Liu, Hui and Tang, XiaoJuan and Jiang, ZhenZhen},
title = {Effects of Esketamine Combined With Remimazolam Tosylate on Hemodynamics During Cardiovascular Anesthesia},
journal = {Clinical and Translational Science},
year = {2025},
volume = {18},
number = {8},
doi = {10.1111/cts.70232}
}
EUVIMED